Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies

Molecular Medicine

Volumn 4, Issue 5, 1998, Pages 333-343

  Fuchs, Jürgen ^a,c   Oelke, Nicole ^a   Imhof, Matthias ^a   Ochsendorf, Falk ^a   Schöfer, Helmut ^a   Oromek, Gerhard ^a   Alaoui Youssefi, Amina ^b   Emerit, Ingrid ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b SORBONNE UNIVERSITÉ   (France)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CD4 ANTIGEN; CLASTOGEN; CYTOKINE; ELASTASE; INTERLEUKIN 2; INTERLEUKIN 6; NEOPTERIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; KAPOSI SARCOMA; OPPORTUNISTIC INFECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031829890     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401740     Document Type: Article

References (94)

1. Goh KO, Sumner H. (1968) Breaks in normal human chromosomes: Are they induced by a transferable substance in the plasma of irradiated persons exposed to total body irradiation? Radiation Res. 6: 51-60.
2. Hollowell JG, Littlefield LG. (1968) Chromosome damage induced by plasma from irradiated patients. An indirect effect of X-rays. Proc. Soc. Exp. Biol. Med. 129: 240-244.
3. Pant GS, Kamada N. (1977) Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals Hiroshima J. Med. Sci. 26: 240-244.
4. Faguet GB, Reichard SM, Welter DA. (1984) Radiation induced clastogenic plasma factors. Cancer Genet. Cytogenet. 12: 73-83.
5. Emerit I. (1994) Reactive oxygen species, chromosome mutation, and cancer: Possible role of clastogenic factors in carcinogenesis. Free Radic. Biol. Med. 16: 99-109.
6. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. (1996) Superoxide mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 93: 12799-12804.
7. Edeas MA, Emerit I, Khalfoun Y, Laizizi Y, Cernjavski L, Levy A, Lindenbaum A. (1997) Clastogenic factors in HIV-1 infected patients activate HIV-1 replication in vitro: Inhibition by superoxide dismutase. Free Radic. Biol. Med. 23: 571-578.
8. Fuchs J, Emerit I, Levy A, Cernjavski I, Schöfer H, Milbradt R. (1995) Clastogenic factors in plasma of HIV-1 infected patients. Free Radic. Biol. Med. 19: 843-848.
9. Adamson GM, Billings RE. (1992) Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch. Biochem. Biophys. 294: 223-229.
10. Mihm S, Ennen J, Pessara U, Kurth R, Droege W. (1991) Inhibition of HIV-1 replication and NF-kappaB activity by cysteine and cysteine derivatives. AIDS 5: 497-504.
11. Fauci AS, Schnittman SM, Poli G, Koening S, Pantaleo G. (1991) Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Int. Med. 114: 678-693.
12. Torresin A, Cassola G, Penco G, Giuliano C, Campanella A, Crisali MP, Persantelli N. (1997) C-reactive protein (CRP) and interleukin 6 (IL-6) in HIV related conditions. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14: A29.
13. Baier-Bitterlich G, Fuchs D, Wachter H. (1997) Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem. Pharmacol. 53: 755-776.
14. Yim CY, Hibbs JB Jr, McGregor JR, Galinsky RE, Samlowski WE. (1994) Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J. Immunol. 152: 5796-5805.
15. Sönnerborg A, Carlin G, Akerlund B, Jarstrand C. (1988) Increased production of malondialdehyde in patients with HIV infection. J. Infect. Dis. 20: 287-290.
16. Eck HP, Gmünder H, Hartmann M, Petzold D, Daniel V, Dröge W. (1989) Low concentration of acid soluble thiol (cystein) in the blood plasma of HIV-1 infected patients. Biol. Chem. Hoppe Seyler 370: 101-108.
17. Buhl R, Holroyd KJ, Cantin AM, Jaffe HA, Wells FB, Saltini C, Crystal RG. (1989) Systemic glutathione-deficiency in symptom-free seropositive individuals. Lancet II: 1294-1298.
18. Folkers K, Langajoen P, Nara Y, Muratsu K, Komorowski J, Richardson PC, Smith TH. (1988) Biochemical deficiencies of coenzyme Q10 in HIV infection and exploratory treatment. Biochem. Biophys. Res. Commun. 153: 888-896.
19. Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W, Sussman H, Raju PA, Anderson MT, Moore W, Ela SW, Herzenberg LA, LA Herzenberg. (1992) Intracellular glutathione levels in T cell subsets decrease in HIV infected individuals. AIDS Res. Hum. Retroviruses 8: 305-311.
20. Fuchs J, Schöfer H, Ochsendorf F, Buhl R, Freisleben HJ, Unkelbach U, Janka S, Oster O, Siems W, Grune T, Esterbauer H, Milbradt R. (1994) Antioxidants and peroxidation products in the blood of HIV infected patients with HIV associated skin disease. Eur. J. Dermatol. 4: 148-153.
21. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. (1994) Antioxidant status and lipid peroxidation in patients infected with HIV. Chem. Biol. Interact. 91: 165-180.
22. Halliwell B, Cross C. (1991) Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Arch. Intern. Med. 151: 29-31.
23. Fuchs J, Ochsendorf F, Schöfer H, Milbradt R, Rübsamen-Weigmann H. (1991) Oxidative imbalance in HIV infected patients. Med. Hypotheses 36: 60-64.
24. Baker DH, Wood RJ. (1994) Cellular antioxidant status and human immunodeficiency virus replication. Nutr. Rev. 50: 15-18.
25. Peterhans E. (1997) Oxidants and antioxidants in viral diseases: Disease mechanisms and metabolic regulation. J. Nutr. 127: 962S-965S.
26. Emerit I. (1990) Clastogenic factors: Detection and assay. Methods Enzymol. 555-564.
27. Emerit I, Filipe P, Meunier P, Auclair C, Freitas J, Deroussent A, Gouyette A, Fernandes A. (1997) Clastogenic activity in the plasma of scleroderma patients: A biomarker of oxidative stress. Dermatology 194: 140-146.
28. Kind CRH, Pepys MB. (1984) The role of serum C-reactive protein (CRP) measurement in clinical practice. Int. Med. 5: 112-151.
29. Thomas L, Messinger M. (1993) Pathobiochemistry and laboratory diagnosis of inflammation. Lab. Med. 17: 179-194.
30. Barak M, Merzbach D, Gruener N. (1989) Neopterin measured in serum and tissue culture supernates by a competitive enzyme-linked immunosorbant assay. Clin. Chem. 35: 1467-1471.
31. Aoki C, Nishimoto N, Deguchi M, Yoshizaki K. (1955) Enzyme immunoassay for cytokines. Nippon Rinsho 53: 2290-2295.
32. Ferrua B, Aussel C, Fehlmann M. (1987) Human interleukin 2. Detection at the picomolar level by sandwich enzyme immunoassay. J. Immunol. Methods 97: 215-220.
33. De Groote D, Gevaert Y, Lopez M, Gathy R, Faucher F, Dehart I, Jadoul M, Radoux D, Franchimont P. (1993) Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267.
34. Emerit I, Khan SH, Esterbauer H. (1991) Hydroxynonenal. A component of clastogenic factors. Free Radic. Biol. Med. 10: 371-377.
35. Auclair C, Gouyette A, Levy A, Emerit I. (1990) Clastogenic inosine nucleotide as components of the chromosome breakage factor in scleroderma patients. Arch. Biochem. Biophys. 278: 238-244.
36. Emerit I, Levy A, Camus JP. (1989) Monocyte derived clastogenic factor in rheumatoid arthritis. Free Radic. Biol. Med. 6: 245-250.
37. Emerit I. (1997) Clastogenic factors as biomarkers of oxidative stress. Their usefulness for evaluation of the efficiency of antioxidant treatments. Presented at Advanced Study Institute (supported by FEBS and NATO). Free Radicals, Oxidative Stress and Antioxidants. Pathological and Physiological Significance. Antalya, Turkey, May 24-June 4, 1997.
38. Cerutti P. (1985) Prooxidant slates and tumor promotion. Science 227: 375-381.
39. Crawford D, Zbinden I, Amstad P, Cerutti P. (1988) Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3: 27-32.
40. Shibanuma MT, Kuroki T, Nose K. (1988) Induction of DNA replication and expression of protooncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine oxidase. Oncogene 3: 17-21.
41. Mallery SR, Bailer RT, Hohl CM, Ng-Bautista CL, Ness GM, Livingston BE, Hout BL, Stephens RE, Brierley GP. (1995) Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: Implication for oxidant stress in AIDS-KS pathogenesis. J. Cell. Biochem. 59: 317-328.
42. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review. J. Infect. Dis. 165: 352-363.
43. Koy A. (1996) Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 1317: 84-94.
44. Matasuyama T, Kobayashi N, Yamamoto N. (1991) Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417.
45. Poli G, Fauci AS. (1992) The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 8: 191-197.
46. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono AM, Raiteri R, Gioannini, P. (1993) Cytokine network and acute primary HIV-1 infection. AIDS 7: 1167-1172.
47. Kundu SK, Merigan TC. (1997) Heterogeneity of cytokine functions in HIV infection. Immunology 91: 234-238.
48. Alonso K, Pontiggia P, Medenica R, Rizzo S. (1997) Cytokine patterns in adults with AIDS. Immunol. Invest. 26: 341-350.
49. Fauci AS. (1988) The human immunodeficiency virus: Infectivity and mechanism of pathogenesis. Science 239: 617-622.
50. Kruppa G, Thoma B, Machleidt T, Wiegmann K, Krönke K. (1992) Inhibition of tumor necrosis factor (TNF)-mediated NF-κB activation by selective blockage of the human 55kDa TNF receptor. J. Immunol. 148: 3152-3157.
51. Peterson PK, Gekker GM, Chao CC, Hu S, Edelman C, Balfour HH Jr. (1992) Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-a mediated mechanism. J. Clin. Invest. 89: 574-580.
52. Emilie D, Fior R, Jarrousse B, Marfaing-Koka A, Merrien D, Devergne O, Crevon MC, Maillot MC, Galanaud P. (1994) Cytokines in HIV Infection. Int. J. Immunopharmacol. 16: 391-396.
53. Roux-Lombard P, Modoux C, Cruchaud A, Dayer JM. (1989) Purified blood monocytes from HIV 1 infected patients produce high levels of TNF alpha and IL-1. Clin. Immunol. Immunopathol. 50: 374-384.
54. Lähdevirta J, Maury CPJ, Teppo AM, Repo H. (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
55. Foli A, Saville MW, May LT, Webb DSA, Yarchoan R. (1997) Effects of human immunodeficiency virus and colony-stimulating factors on the production of interleukin 6 and tumor necrosis factor alpha by monocyte-macrophages. AIDS Res. Hum. Retroviruses 13: 829-839.
56. Baldwin AS. (1996) The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-681.
57. Schreck R, Rieber P, Baeuerle PA. (1991) Reactive oxygen intermediates as apparently widely used second messengers in the activation of the NFκB transcription factor and HIV-1. Eur. Mol. Biol. Org. J. 10: 2247-2258.
58. Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, Bours V. (1996) Interleukin-1β induces nuclear factor κB in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242: 544-549.
59. Brennan P, O'Neill LAJ. (1995) Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: Evidence against an universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260: 167-175.
60. Legrand-Poels S, Zecchinon L, Piret B, Schoonbroodt S, Piette J. (1997) Involvement of different transduction pathways in NF-κB activation by several inducers. Free Radic. Res. 27: 301-309.
61. Wong GHW. (1992) MnSOD Induction by TNF-α and its protective role. In: Beutler B (ed). Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, New York, pp. 473-448.
62. Sato M, Sasaki M, Hojo H. (1995) Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. Arch. Biochem. Biophys. 316: 738-774.
63. Beutler B, Cerami A. (1988) The history properties and biological effects of cachectin. Biochemistry 27: 7575-7578.
64. Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, Fauci AS. (1996) Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum. Retroviruses 12: 759-767.
65. Mikhalchik EV, Kharaeva ZF, Kovachuk IV, Shiyan SD, Korkina LG. (1996) Effect of interleukin-2 and gamma-interferon on "respiratory burst" in macrophages: Changes in the intracellular radical production and carbohydrate-specific interactions. Biologicheskie Membrany (Moscow) 13: 361-369.
66. Chirmule N, Kalyanaraman VS, Oyaizu N, Slade HB, Pahwa S. (1990) Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus. Blood 75: 152-159.
67. Cauda R, Tumbarello M, Ortona L, Kennedy RC, Shuler KR, Chanh TC, Kanda P. (1990) Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides. Nat. Immun. Cell Growth Regul. 9: 366-375.
68. + T-cells and this effect overrides its ability to stimulates virus expression. Proc. Natl. Acad. Sci. U.S.A. 92: 10985-10989.
69. Garbe C. (1995) Perspectives of cytokine treatment in malignant skin tumors. Recent Results Cancer Res. 139: 349-369.
70. Clerici M, Roilides E, Butler KM, DePalma L, Venzon D, Shearer GM, Pizzo PA. (1992) Changes in T-helper cell function in human immunodeficiency virus infected children during didanosine therapy as a measure of antiretroviral activity. Blood 80: 2196-2202.
71. Zollner B, Feucht HH, Hamann A, Laufs R. (1995) Influence of exogenous interleukin-2 concentration on the isolation of human immunodeficiency virus. Microbiol. Immunol. 39: 117-121.
72. Kishimoto T. (1989) The biology of interleukin-6. Blood 74: 1-10.
73. Van Snick J. (1990) Interleukin-6: An overview. Annu. Rev. Immunol. 8: 253-278.
74. Zhou D, Munster A, Windurch RA. (1993) Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. Microbiologia 16: 115-120.
75. + T cell clones. J. Virol. 65: 6277-6282.
76. Zauli G, Furlini G, Re MC, Milani D, Capitani S, La-Placa M. (1993) Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes. Microbiologica 16: 115-120.
77. Marfaing-Koka A, Aubin JT, Grangeot-Keros L, Portier A, Benattar C, Merrien D, Agut H, Aucouturier P, Autran B, Wijdenes J. (1996) In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11: 59-66.
78. Samaniego F, Markham PD, Gallo RC, Ensoli B. (1995) Inflammatory cytokines induce AIDS-Kaposi's sarcoma derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma like lesion formation in nude mice. J. Immunol. 154: 3582-3592.
79. Lazutka JR. (1996) Genetic toxicity of cytokines. Mutat. Res. 361: 95-105.
80. Duff GW. (1994) Cytokines and acute phase proteins in rheumatoid arthritis. Scand. J. Rheumatol. 100 (Suppl): 9-19.
81. Dinarello CA. (1984) Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med. 311: 1413-1416.
82. Polevishchikov AB, Nazarov PG. (1993) Immunocytotropic effects of C-reactive protein. Immunologiya 4: 6-10.
83. Hennig, EM. (1995) C-reactive prolein (CRP) and biological defence. Tidsskr. Nor. Laegeforen. 115: 1632-1635.
84. Syrjala H, Lahdevirta J, Ruutu P, Jokipii AMM, Ruutu T. (1990) Acute phase response in Pneumocystis carinii pneumonia. Scand. J. Infect. Dis. 22: 713-716.
85. Schmidt-Mathiesen A, Oreme G. (1990) C-reaktives Prolein zur Erkennung postoperativer infektiöser Komplikationen. Chirurg 61: 895-899.
86. Vaishnavi C. (1996) C-reactive protein in bacterial infections. Immunol. Infect. Dis. 6: 139-144.
87. Baier-Bitterlich G, Wachter H, Fuchs D. (1996) Role of neopterin and 7,8-dihydroneopterin in human immunodeficiency virus infection: Marker for disease progression and pathogenic link. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13: 184-193.
88. Schobersberger W, Hoffmann G, Hobisch-Hagen P, Boeck G, Voelkl H, Baier-Bitterlich G, Wirleitner B, Wachter H, Fuchs D. (1996) Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett. 397: 263-268.
89. Baier-Bitterlich G, Fuchs D, Murr C, Reibenegger G, Werner-Felmayer G, Sgonc R, Boeck G, Dierich MP, Wachter H. (1995) Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-alpha induced programmed cell death. FEBS Lett. 364: 234-239.
90. Jones DW, Winter M, Gallimore M, Mason C. (1994) Increased release of granulocyte elastase associated with HIV infection. Br. J. Haematol. 86 (Suppl 1): 91.
91. Miesel R, Hartung R, Kroeger H. (1996) Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic disease. Inflammation 20: 427-438.
92. Dittmer H, Jochum M, Fritz H. (1986) Freisetzung von granulozytärer Elastase und Plasma-protein-veränderungen nach traumatisch-hämorrhagischem Schock. Unfallchirurg 89: 160-169.
93. Nast-Kolb D, Waydhas C, Jochum M. (1992) Biochemische Faktoren als objektive Parameter zur Prognoseabschätzung beim Polytrauma. Unfallchirurg 95: 59-66.
94. Windolf J, Oremek G, Inglis R, Zega A. (1994) Prospektive Validierung der PMN Elastase als Verlaufsparameter auf der unfallchirurgischen Intensivstation. Unfallchirurgie 20: 239-250.